Floatz logo

Neoantigen Reactive T Cells

Nicotine Dependence

The University of Texas Health Science Center, HoustonCell therapyPhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Nicotine Dependence cohort.

Asset / SponsorPhaseRating
Varenicline Tartrate
University of California, San Diego
Phase 4BBB
FLUOXETINE
Butler Hospital
Phase 3BB
DEXTROSE
Butler Hospital
Phase 3BB

Same molecule, other indications

Neoantigen Reactive T Cells is also rated in:

SchizophreniaDormant
B
Indicative ·
56 / 100
View asset →
HCCDormant
CC
Indicative ·
45 / 100
View asset →
Advanced Malignant Solid TumorDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →